Genotech (XKON:A066830) - Stock Price, News & Analysis

A066830 Stock Overview

Provides products and services for gene synthesis, genome analysis, and biopharmaceuticals in South Korea and internationally. More details

A066830 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (₩8B)

Genotech Corporation Competitors

Clinomics

KOSDAQ:A352770

₩18.3b

OLIPASS

KOSDAQ:A244460

₩20.6b

NeoImmuneTech

KOSDAQ:A950220

₩23.9b

GeneBioTech Ltd

KOSDAQ:A086060

₩29.5b

Price History & Performance

Summary of all time highs, changes and price drops for Genotech
Historical stock prices
Current Share Price	₩1,397.00
52 Week High	₩2,100.00
52 Week Low	₩1,250.00
Beta	0
11 Month Change	-0.072%
3 Month Change	-12.36%
1 Year Change	-30.08%
33 Year Change	-62.14%
5 Year Change	-22.17%
Change since IPO	-77.28%

Recent updates

Shareholder Returns

	A066830	KR Biotechs	KR Market
7D	0.1%	-5.8%	-2.8%
1Y	-30.1%	28.2%	-3.4%

Return vs Industry: A066830 underperformed the KR Biotechs industry which returned 28.2% over the past year.

Return vs Market: A066830 underperformed the KR Market which returned -3.4% over the past year.

Price Volatility

Is A066830's price volatile compared to industry and market?
A066830 volatility
A066830 Average Weekly Movement	8.1%
Biotechs Industry Average Movement	8.3%
Market Average Movement	5.7%
10% most volatile stocks in KR Market	11.5%
10% least volatile stocks in KR Market	2.7%

Stable Share Price: A066830 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A066830's weekly volatility (8%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1997	n/a	n/a	www.genotech.co.kr

Genotech Corporation provides products and services for gene synthesis, genome analysis, and biopharmaceuticals in South Korea and internationally. The company offers standard, modified, dual labeled, and synthesis oligonucleotides; and gene synthesis services. It also provides sanger DNA sequencing services, which includes standard DNA, 16S/ITS, and insert clone sequencing, as well as primer walking; next generation sequencing; bioinformatics services; genomic services, such as SNP discovery/analysis and sequence finishing; and molecular diagnostic kits.

Genotech Corporation Fundamentals Summary

How do Genotech's earnings and revenue compare to its market cap?
A066830 fundamental statistics
Market cap	₩7.82b
Earnings (TTM)	₩0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is A066830 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A066830 income statement (TTM)
Revenue	₩0
Cost of Revenue	₩0
Gross Profit	₩0
Other Expenses	₩0
Earnings	₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did A066830 perform over the long term?

See historical performance and comparison

Genotech XKON:A066830 Stock Report